Targeting CXCR7/ACKR3 as a therapeutic strategy to promote remyelination in the adult central nervous system

Journal of Experimental Medicine

Volumn 211, Issue 5, 2014, Pages 791-799

  Williams, Jessica L ^a   Patel, Jigisha R ^a   Daniels, Brian P ^a   Klein, Robyn S ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; CUPRIZONE; MYELIN; PHOSPHOSPECIFIC ANTIBODY; PLERIXAFOR; SERINE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DEMYELINATION; DRUG EFFECT; IN VITRO STUDY; IN VIVO STUDY; MALE; MEDIATOR; MOLECULE; MOUSE; NEURAL STEM CELL; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; REMYELINIZATION;

ANALYSIS OF VARIANCE; ANIMALS; AXONS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CENTRAL NERVOUS SYSTEM; HETEROCYCLIC COMPOUNDS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; MYELIN SHEATH; OLIGODENDROGLIA; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, CXCR; RECEPTORS, CXCR4; STEM CELLS;

EID: 84899742849     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20131224     Document Type: Article

References (32)

1. Arnett, H.A., J. Mason, M. Marino, K. Suzuki, G.K. Matsushima, and J.P. Ting. 2001. TNFα promotes proliferation of oligodendrocyte progenitors and remyelination. Nat. Neurosci. 4:1116-1122. http://dx.doi.org/10.1038/nn738
2. Bajetto, A., R. Bonavia, S. Barbero, P. Piccioli, A. Costa, T. Florio, and G. Schettini. 1999. Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J. Neurochem. 73:2348-2357. http://dx.doi.org/10.1046/j.1471-4159.1999.0732348.x
3. Banisadr, G., D. Skrzydelski, P. Kitabgi, W. Rostène, and S.M. Parsadaniantz. 2003. Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur. J. Neurosci. 18:1593-1606. http://dx.doi.org/10.1046/j.1460-9568.2003.02893.x
4. Boldajipour, B., H. Mahabaleshwar, E. Kardash, M. Reichman-Fried, H. Blaser, S. Minina, D. Wilson, Q. Xu, and E. Raz. 2008. Control of chemokineguided cell migration by ligand sequestration. Cell. 132:463-473. http://dx.doi.org/10.1016/j.cell.2007.12.034
5. Calderon, T.M., E.A. Eugenin, L. Lopez, S.S. Kumar, J. Hesselgesser, C.S. Raine, and J.W. Berman. 2006. A role for CXCL12 (SDF-1α) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177:27-39. http://dx.doi.org/10.1016/j.jneuroim.2006.05.003
6. Carbajal, K.S., C. Schaumburg, R. Strieter, J. Kane, and T.E. Lane. 2010. Migration of engrafted neural stem cells is mediated by CXCL12 signaling through CXCR4 in a viral model of multiple sclerosis. Proc. Natl. Acad. Sci. USA. 107:11068-11073. http://dx.doi.org/10.1073/pnas.1006375107
7. Carbajal, K.S., J.L. Miranda, M.R. Tsukamoto, and T.E. Lane. 2011. CXCR4 signaling regulates remyelination by endogenous oligodendrocyte progenitor cells in a viral model of demyelination. Glia. 59:1813-1821. http://dx.doi.org/10.1002/glia.21225
8. Chang, A., A. Nishiyama, J. Peterson, J. Prineas, and B.D. Trapp. 2000. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J. Neurosci. 20:6404-6412.
9. Chang, A., W.W. Tourtellotte, R. Rudick, and B.D. Trapp. 2002. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N. Engl. J. Med. 346:165-173. http://dx.doi.org/10.1056/NEJMoa010994
10. Compston, A., and A. Coles. 2002. Multiple sclerosis. Lancet. 359:1221-1231. http://dx.doi.org/10.1016/S0140-6736(02)08220-X
11. Cruz-Orengo, L., Y.J. Chen, J.H. Kim, D. Dorsey, S.K. Song, and R.S. Klein. 2011a. CXCR7 antagonism prevents axonal injury during experimental autoimmune encephalomyelitis as revealed by in vivo axial diffusivity. J. Neuroinflammation. 8:170. http://dx.doi.org/10.1186/1742-2094-8-170
12. Cruz-Orengo, L., D.W. Holman, D. Dorsey, L. Zhou, P. Zhang, M. Wright, E.E. McCandless, J.R. Patel, G.D. Luker, D.R. Littman, et al. 2011b. CXCR7 influences leukocyte entry into the CNS parenchyma by controlling abluminal CXCL12 abundance during autoimmunity. J. Exp. Med. 208:327-339. http://dx.doi.org/10.1084/jem.20102010
13. Dziembowska, M., T.N. Tham, P. Lau, S. Vitry, F. Lazarini, and M. Dubois-Dalcq. 2005. A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors. Glia. 50:258-269. http://dx.doi.org/10.1002/glia.20170
14. Franklin, R.J., and C. Ffrench-Constant. 2008. Remyelination in the CNS: from biology to therapy. Nat. Rev. Neurosci. 9:839-855. http://dx.doi.org/10.1038/nrn2480
15. Göttle, P., D. Kremer, S. Jander, V. Odemis, J. Engele, H.P. Hartung, and P. Küry. 2010. Activation of CXCR7 receptor promotes oligodendroglial cell maturation. Ann. Neurol. 68:915-924. http://dx.doi.org/10.1002/ana.22214
16. Hatse, S., K. Princen, G. Bridger, E. De Clercq, and D. Schols. 2002. Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4. FEBS Lett. 527:255-262. http://dx.doi.org/10.1016/S0014-5793(02)03143-5
17. Imitola, J., K. Raddassi, K.I. Park, F.J. Mueller, M. Nieto, Y.D. Teng, D. Frenkel, J. Li, R.L. Sidman, C.A. Walsh, et al. 2004. Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1α/CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. USA. 101:18117-18122. http://dx.doi.org/10.1073/pnas.0408258102
18. Klein, R.S., and J.B. Rubin. 2004. Immune and nervous system CXCL12 and CXCR4: parallel roles in patterning and plasticity. Trends Immunol. 25:306-314. http://dx.doi.org/10.1016/j.it.2004.04.002
19. Kuhlmann, T., V. Miron, Q. Cui, C. Wegner, J. Antel, and W. Brück. 2008. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain. 131:1749-1758. http://dx.doi.org/10.1093/brain/awn096
20. Lindner, M., S. Heine, K. Haastert, N. Garde, J. Fokuhl, F. Linsmeier, C. Grothe, W. Baumgärtner, and M. Stangel. 2008. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol. Appl. Neurobiol. 34:105-114.
21. Matsuo, A., G.C. Lee, K. Terai, K. Takami, W.F. Hickey, E.G. McGeer, and P.L. McGeer. 1997. Unmasking of an unusual myelin basic protein epitope during the process of myelin degeneration in humans: a potential mechanism for the generation of autoantigens. Am. J. Pathol. 150:1253-1266.
22. McCandless, E.E., Q. Wang, B.M. Woerner, J.M. Harper, and R.S. Klein. 2006. CXCL12 limits inflammation by localizing mononuclear infiltrates to the perivascular space during experimental autoimmune encephalomyelitis. J. Immunol. 177:8053-8064.
23. McCandless, E.E., L. Piccio, B.M. Woerner, R.E. Schmidt, J.B. Rubin, A.H. Cross, and R.S. Klein. 2008. Pathological expression of CXCL12 at the blood-brain barrier correlates with severity of multiple sclerosis. Am. J. Pathol. 172:799-808. http://dx.doi.org/10.2353/ajpath.2008.070918
24. Naumann, U., E. Cameroni, M. Pruenster, H. Mahabaleshwar, E. Raz, H.G. Zerwes, A. Rot, and M. Thelen. 2010. CXCR7 functions as a scavenger for CXCL12 and CXCL11. PLoS ONE. 5:e9175. http://dx.doi.org/10.1371/journal.pone.0009175
25. Patel, J.R., E.E. McCandless, D. Dorsey, and R.S. Klein. 2010. CXCR4 promotes differentiation of oligodendrocyte progenitors and remyelination. Proc. Natl. Acad. Sci. USA. 107:11062-11067. http://dx.doi.org/10.1073/pnas.1006301107
26. Patel, J.R., J.L. Williams, M.M. Muccigrosso, L. Liu, T. Sun, J.B. Rubin, and R.S. Klein. 2012. Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. Acta Neuropathol. 124:847-860. http://dx.doi.org/10.1007/s00401-012-1034-0
27. Schönemeier, B., S. Schulz, V. Hoellt, and R. Stumm. 2008. Enhanced expression of the CXCl12/SDF-1 chemokine receptor CXCR7 after cerebral ischemia in the rat brain. J. Neuroimmunol. 198:39-45. http://dx.doi.org/10.1016/j.jneuroim.2008.04.010
28. Steinman, L. 2009. A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9:440-447. http://dx.doi.org/10.1038/nri2548
29. Wolswijk, G. 1998. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells. J. Neurosci. 18:601-609.
30. Xu, H., and S.C. Heilshorn. 2013. Microfluidic investigation of BDNFenhanced neural stem cell chemotaxis in CXCL12 gradients. Small. 9: 585-595. http://dx.doi.org/10.1002/smll.201202208
31. Zhu, Y., T. Matsumoto, S. Mikami, T. Nagasawa, and F. Murakami. 2009. SDF1/CXCR4 signalling regulates two distinct processes of precerebellar neuronal migration and its depletion leads to abnormal pontine nuclei formation. Development. 136:1919-1928. http://dx.doi.org/10.1242/dev.032276
32. Zou, Y.R., A.H. Kottmann, M. Kuroda, I. Taniuchi, and D.R. Littman. 1998. Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development. Nature. 393:595-599. http://dx.doi.org/10.1038/31269